Skip to main content
Equibles

FULLER & THALER ASSET MANAGEMENT, INC.

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1082327 SAN MATEO, CA
Back to HALO Full portfolio

Position in HALO

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$116,700,883
+$21,999,643 QoQ
Shares Held
1,491,004
+1.8% QoQ
Ownership
1.31%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#20
of 667 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority Sole 95% Shared 0% None 5%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FULLER & THALER ASSET MANAGEMENT, INC. holds $1,207,612,518 across 7 Biotechnology names. HALO ranks #3 (9.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 EXEL
Exelixis, Inc.
 8,929,389 $485,848,055
2 JAZZ
Jazz Pharmaceuticals plc
 1,638,544 $394,839,947
3 HALO
Halozyme Therapeutics, Inc.
This page 		1,491,004 $116,700,883
4 PTCT
Ptc Therapeutics, Inc.
 1,156,819 $94,361,725
5 CORT
Corcept Therapeutics Inc
 710,106 $61,743,716
6 CELC
Celcuity Inc.
 514,396 $53,816,109
7 VNDA
Vanda Pharmaceuticals Inc.
 49,360 $302,083

All Filings in HALO

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $116,700,883 1,491,004
2026-03-31 $94,701,240 1,465,283
2025-12-31 $92,845,397 1,379,575
2025-09-30 $100,562,634 1,371,184
2025-06-30 $64,661,276 1,243,008
2025-03-31 $72,106,512 1,130,019
2024-12-31 $42,448,204 887,852
2024-09-30 $47,139,658 823,544
2024-06-30 $37,519,762 716,573
2024-03-31 $23,120,925 568,361
2023-12-31 $15,141,846 409,682
2023-09-30 $14,072,650 368,394
2023-06-30 $12,191,732 338,002
2021-12-31 $11,229,165 279,263
2021-09-30 $11,519,925 283,184
2021-06-30 $13,978,696 307,833
2021-03-31 $15,817,644 379,411
2020-12-31 $15,927,285 372,917
2020-09-30 $9,599,321 365,271
2020-06-30 $10,708,074 399,406
2020-03-31 $6,641,890 369,199